Background: Suboptimal diet results in significant health and economic burdens. However, the global economic costs of dietary risks remain unclear.
Objective: This study aimed to estimate the macroeconomic burden of 15 dietary risk factors in 204 countries and territories from 2020-2050.
Methods: This health-augmented macroeconomic modeling study assessed the macroeconomic burden that accounted for decrease in labor supply across different education levels due to mortality and morbidity, and the impact of healthcare expenses on investment and savings. Country-specific data were drawn from publicly accessible databases. The cumulative difference in the aggregate output between a realistic scenario without intervention and a counterfactual scenario assuming complete disease elimination was quantified as the macroeconomic burden attributable to diseases. The proportion of disease burden attributed to dietary risk factors was quantified using population attributable fractions derived from the Global Burden of Disease study 2019, which was integrated into the health-augmented macroeconomic model. Estimates were converted to 2017 international dollars (INT $).
Results: The estimated global macroeconomic burden attributable to dietary risks from 2020-2050 was INT $15491 (UI 13078, 18742) billion, representing 0.34% (UI 0.29%, 0.41%) of the total gross domestic product. The macroeconomic burden was unevenly distributed across countries, regions, income groups, disease types, and dietary risk factors. The USA (INT $3972 billion), China (INT $2764 billion), and India (INT $1300 billion) had the largest macroeconomic burden. Ischemic heart disease (INT $9384 billion), diabetes (INT $2392 billion), and stroke (INT $1954 billion) accounted for ∼90% of the overall macroeconomic burden. Diet low in whole grains (INT $3808 billion) incurred the highest cost, followed by diet high in sodium (INT $2812 billion) and red meat (INT $2337 billion).
Conclusions: The global macroeconomic burden attributable to dietary risks was substantial and varied across countries, regions, income groups, disease types, and individual dietary risk factors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ajcnut.2025.03.002 | DOI Listing |
Am J Clin Nutr
March 2025
Department of Epidemiology and Biostatistics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
Background: Suboptimal diet results in significant health and economic burdens. However, the global economic costs of dietary risks remain unclear.
Objective: This study aimed to estimate the macroeconomic burden of 15 dietary risk factors in 204 countries and territories from 2020-2050.
Healthcare (Basel)
February 2025
Department of Organization and Economy of Pharmacy, Faculty of Pharmacy, Medical University-Sofia, 1000 Sofia, Bulgaria.
Background: Type 2 diabetes is a chronic disease with high global prevalence and significant social and economic burden. The pandemic affected patients' diagnostics and medicines dispensing. Diabetes was among the most-affected conditions during lockdown due to the limited resources and unaffordable medicines.
View Article and Find Full Text PDFBMJ Glob Health
February 2025
Health Systems Innovation Lab, Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Introduction: There is a dearth of evidence regarding the global economic burden of ischaemic heart diseases (IHDs). This systematic review aims to synthesise national-level studies worldwide quantifying the economic burden of IHDs from a provider's perspective.
Methods: We searched PubMed, Embase, Cochrane, DARE and EconLit databases from 1 January 2000 to 29 June 2022.
Access to medicines remains a significant challenge in low-and middle-income countries. In Nigeria, access to medicines is particularly difficult due to a mix of factors such as high out-of-pocket expenditure, inequitable distribution of healthcare facilities, and health workforce brain drain. Recently, this has been further exacerbated by adverse macroeconomic factors such as high inflation and currency devaluation due to weak international trade.
View Article and Find Full Text PDFPLoS Med
December 2024
Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Background: Tuberculosis (TB) imposes a substantial health and economic burden on many populations and countries, but lack of funding has significantly contributed to several countries falling short of global TB reduction targets. Furthermore, existing assessments of the economic impact of TB do not capture the impacts on productivity and economic growth or the pathways by which epidemiology, demography, and the economy interact. Evidence is needed to answer how investment in treatment and control measures may help to mitigate the twin Indian health and macroeconomic burdens of TB over the coming decades.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!